Navigation Links
Oncothyreon to receive milestone payment
Date:5/14/2008

BELLEVUE, WA, May 14 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) (the "Company") today announced that it has completed the transfer of certain assays and manufacturing technology related to Stimuvax(R) (BLP25 liposome vaccine) to Merck KGaA of Darmstadt, Germany, triggering a payment to Oncothyreon of $3 million. The payment will be made under the terms of the amended and restated supply agreement signed in August 2007.

Stimuvax is an investigational therapeutic cancer vaccine designed to induce an immune response to cancer cells that express MUC1, a glycoprotein antigen widely expressed on common cancers. Merck KGaA currently is conducting a global Phase 3 trial of Stimuvax known as START (Stimulating Targeted Antigenic Responses To NSCLC). START is a randomized, double-blind, placebo-controlled study that will evaluate patients with documented unresectable stage III NSCLC who have had a response or stable disease after at least two cycles of platinum based chemo-radiotherapy. The trial is expected to enroll more than 1,300 patients in approximately 30 countries. For more information on the START trial, or to find a participating center and eligibility criteria, log on to http://www.nsclcstudy.com or http://www.clinicaltrials.gov.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information visit http://www.oncothyreon.com.

Forward-Looking Statements

In order to provide Oncothyreon's investors with an understanding of its current intentions and f
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncothyreon Reports First Quarter 2008 Financial Results
2. Oncothyreon files investigational new drug application for PX-866 oncology compound
3. Data for Oncothyreons PX-12 and PX-866 presented at AACR Annual Meeting
4. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
5. Oncothyreon announces effectiveness of shelf registration statement
6. Oncothyreon announces issuance of patent for PX-867
7. Oncothyreon to present at upcoming investment conferences
8. Oncothyreon reports full year and fourth quarter 2007 financial results
9. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
10. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
11. Oncothyreon launches new corporate website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...FirstCall/ -- Eli Lilly and,Company (NYSE: LLY ) ...ion,of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP ),...n drug discovery and development in the area,of on...s Special,Stockholders Meeting, in which a majorit... agreement with Lilly. Under the agreement, Lilly ...
(Date:8/20/2008)... and Caregivers, Grassroots ...ewswire-USNewswire/ -- Inc. Magazine has,named Sen...an for,low-income seniors, the number one fastest-...rt of Inc.,s annual list of the country,s 500 fast...1,000 percent from 2004 to 2007., "This is a rewa...
(Date:8/20/2008)...ll/ -- CEL-SCI CORPORATION,(Amex: CVM ) reports f...ing,June 30, 2008., The Company,s loss from opera...76,679 versus a loss of $3,776,263 during the same...ns for the nine months ended June 30, 2008,was $7,...e nine months in,2007., The net loss per common s...
(Date:8/20/2008).../ -- Huifeng Bio-Pharmaceutical,Technology, Inc (O...producer of plant extracts and pharmaceutical raw ... and food production, today announced it will,be i... August 19-21 in Rio,de Janeiro, Brazil., "Unpara...volved in the,pharmaceutical raw materials industr...
Breaking Biology Technology:Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 2CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 4CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 5Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil 2
... this column, I have become aware of a lot of life...he Midwest. Part of the challenge of this column h... ,Though many Midwest life science companies are w... the radar screen of awareness. Rarely, however, h...company (particularly a publicly traded company). ...
...four-year-old conference draws nearly 1,000 people...power of technology. As the lead speaker on a two-...onomic and Social Conditions, I was eager, frankly...gy indicators in order to hear from and debate my ...personal and corporate time a very un-French conc...
... non-profit arm the SBC Foundation, has given $285...-profits, the Business Journal of Milwaukee has r...e social services to at-risk youth and underserved...technology. The grants were part of SBC,s Exceler...o $25,000 per organization. , ,Ten of the 24 grant...
...While the Madison chapter of the World Future Soc...new social and technological developments, Scott C...so be important if they want to see where the next...tion technology director at the UW-Madison School ...m Cant Dance Technologies, spoke to the society on...
Other Biology Technology:Bio-Logic Systems, another Midwest life-science firm, flies under the radar 2Bio-Logic Systems, another Midwest life-science firm, flies under the radar 3Bio-Logic Systems, another Midwest life-science firm, flies under the radar 4Achieving digital solidarity 2Achieving digital solidarity 3Achieving digital solidarity 4Business-school IT director points to reasons for wireless trend 2
(Date:8/20/2008)...radable polymers called polyketals and their deriv... illnesses as acute lung injury, acute liver failu...ugs, proteins and snips of ribonucleic acid to dis...roparticles we developed are simply a vehicle to g...as quickly as possible," said Niren Murthy, assist...
(Date:8/20/2008)...enome Research Institute (NHGRI), part of the Nati...e than $20 million in grants to develop innovative... enough to sequence a person,s DNA as a routine pa...he ability to comprehensively sequence any person,...er in an age of personalized medicine where health...
(Date:8/19/2008)...l gonadotrophs , Although the basic developmen... has been harder to associate specific changes in ... cell population. In an article on p. 546 of the S... Feng et al. take the approach of comparing the nu... were immortalized at different stages of developm...
(Date:8/19/2008)...just for livening up boring bran flakes; it can al...chers at the National Institute of Standards and T...e and effective method for evaluating the sugars p...rugs for storage at room temperature. The group pr...ical Society National Meeting and Exposition. , ...
Breaking Biology News(10 mins):Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 5September 2008 Biology of Reproduction highlights 2Candy-coating keeps proteins sweet 2Genes identified that protect against heart damage from chemotherapy 7460 1Genes identified that protect against heart damage from chemotherapy 7460 2CU Boulder technology used to identify unexpected bacteria in cystic fibrosis patients 1437 1CU Boulder technology used to identify unexpected bacteria in cystic fibrosis patients 1437 2Almost 1 in 5 Americans Going Without Health Care 7454 1Almost 1 in 5 Americans Going Without Health Care 7454 2Almost 1 in 5 Americans Going Without Health Care 7454 3ING Employee Benefits Announces New Critical Illness Insurance Product 7449 1ING Employee Benefits Announces New Critical Illness Insurance Product 7449 2ING Employee Benefits Announces New Critical Illness Insurance Product 7449 3
...of Texas M. D. Anderson Cancer Center have develop...Tarceva and the widely used chemotherapy drug Taxo...at with further refinement, the test may make it p...responding to these agents, as well as potentially...wo different studies being presented at the annual...
...annexin 1 may protect patients from the detrimenta..., as reported by researchers at Barts and the Lond... The paper by Damazo et al., "Critical protective ...mic murine microcirculation," appears in the June ...accompanied by a commentary. , Severe inflammatory...
...job of keeping the doctor away than others, accord...ular varieties of the fruit. Red Delicious, Northe...p of disease-fighting antioxidants than other appl...Ph.D., of Agriculture and Agri-Food Canada in Guel...al compounds responsible for antioxidant activity ...
...otein that could unlock the secret to quicker, mor...in the body. Once the TB bacteria are active again... like antibiotics. Scientists believe that uncover...ead the way to designing drugs which enable treatm...gland and Wales around 400 people die each year fr...
Other Biology News:Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol 2Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol 3Protein prevents detrimental immune effects of bacterial sepsis 2Red delicious, Northern Spy apples have most antioxidants, chemists find 2
...ontaining an overproducing clone of T4 DNA Ligase....n of a phosphodiester bond between juxtaposed 5' ...r RNA. It repairs single-stranded nicks in duplex ...nt-end and cohesive-end fragments of duplex DNA or...
SHEEP ANTI BOVINE BETA-LACTOGLOBULIN A
Recorder, 6", 7 Day, 1 Pen, 0 to 100°C, 220V, 50/60 Hz, for 4520, Customer Installed
...-Ring Stand is designed for paramagnetic bead prec...es. The stand has a plastic base in a standard SBS... extremely strong permanent magnetic rings enables...etic stand, paramagnetic beads in a U-bottom plate...
Biology Products: